TNF alpha Non-Human Primate ProcartaPlex™ Simplex Kit
TNF alpha Non-Human Primate ProcartaPlex™ Simplex Kit
Invitrogen™

TNF alpha Non-Human Primate ProcartaPlex™ Simplex Kit

Das ProcartaPlex Simplex-Kit TNF-alpha (nichtmenschlicher Primat) misst das TNF-alpha-Protein und ist so konzipiert, dass es mit anderen Simplex-Kits kombiniert werdenWeitere Informationen
Have Questions?
KatalognummerMenge
EPX01A-40223-90196 Tests
Katalognummer EPX01A-40223-901
Preis (EUR)
349,00
Each
Zum Warenkorb hinzufügen
Menge:
96 Tests
Preis (EUR)
349,00
Each
Zum Warenkorb hinzufügen
Das ProcartaPlex Simplex-Kit TNF-alpha (nichtmenschlicher Primat) misst das TNF-alpha-Protein und ist so konzipiert, dass es mit anderen Simplex-Kits kombiniert werden kann, sodass Sie Ihr eigenes Multiplex-Panel erstellen können, das die Luminex xMAP Technologie für die Proteindetektion/Quantifizierung nutzt. Zur Kombination mehrerer Simplex-Kits (d. h. wenn Sie kein vorkonfiguriertes Multiplex-Panel verwenden) wird für jede Assay-Platte unabhängig von der Plex-Größe nur ein Pufferkit (separat erhältlich) benötigt.

Informationen zu ProcartaPlex Assays für die Luminex Plattform

ProcartaPlex Immunassays basieren auf den Prinzipien eines Sandwich-ELISA und verwenden zwei hochspezifische Antikörper, die an verschiedene Epitope eines Proteins gebunden sind, um alle Proteinziele gleichzeitig mit einem Luminex Gerät zu quantifizieren. ProcartaPlex Multiplex-Assays benötigen nur 25 µl Plasma oder Serum bzw. 50 µl Zellkulturüberstand und es dauert nur vier Stunden, bis analysierte Ergebnisse zur Verfügung stehen.

Mehr Ergebnisse pro Probe – gleichzeitige Messung mehrerer Proteinziele in einer einzigen Probe von 25 bis 50 µl

Bewährte Luminex Technologie – vielfach referenzierte Multiplexing-Plattform zur Proteindetektion und -quantifizierung

ProcartaPlex Assays nutzen die Luminex xMAP Technologie (Multianalyt-Profiling) zur gleichzeitigen Detektion und Quantifizierung von bis zu 65 Proteinzielen in einer einzigen 25 bis 50 µl-Probe aus Plasma, Serum, Zellkulturüberständen und anderen Körperflüssigkeiten.

Die Luminex Beads im ProcartaPlex Assay sind intern mit roten und infraroten Fluorophoren in präzisem Verhältnis zueinander gefärbt, um spektral einzigartige Signaturen zu erzeugen, die von den Luminex xMAP Detektionssystemen (z. B. Luminex 200, FLEXMAP 3D und MAGPIX) erkannt werden können. Ähnlich wie bei einem Sandwich-ELISA verwendet der ProcartaPlex Assay zusammenpassende Antikörperpaare, um das zu untersuchende Protein zu identifizieren. In einem Multiplex-Assay wird jeder spektral einzigartige Bead mit spezifischen Antikörpern für ein einzelnes Zielprotein markiert, und gebundene Proteine werden mit biotinylierten Antikörpern und Streptavidin-R-Phycoerythrin (RPE) identifiziert. Die Konjugation von Protein-spezifischen Antikörpern an bestimmte Beads ermöglicht die Analyse mehrerer Ziele in einem einzelnen Well.

Der wichtigste Unterschied zwischen einem ProcartaPlex Assay und ELISA besteht darin, dass der Capture-Antikörper im ProcartaPlex Assay an ein Bead konjugiert und nicht an das Mikrotiterplatten-Well adsorbiert, sodass die ProcartaPlex Assayreagenzien frei in der Lösung schwimmen. Zum Nachweis verfügt das Luminex 200 Gerät beispielsweise über zwei Laser, einen zur Unterscheidung der spektralen Signatur jedes Beads und den zweiten zur Quantifizierung der RPE-Fluoreszenz, die proportional zur in der Probe vorhandenen Proteinmenge ist. Mit ProcartaPlex Multiplex-Assays können mehr Zielproteine mit deutlich weniger Proben in der gleichen Zeit profiliert werden, die für die Durchführung eines herkömmlichen Sandwich-ELISA benötigt wird.

ProcartaPlex Multiplex-Panel sind in verschiedenen Formaten für sechs Spezies erhältlich (Mensch, Maus, Ratte, nichtmenschlicher Primat, Schwein und Hund). Weitere Informationen sowie eine umfassenden Liste einzelner Proteinziele finden Sie unter thermofisher.com/procartaplex.

Nur für Forschungszwecke. Nicht zur Verwendung bei diagnostischen Verfahren.

Specifications
Assay-BereichAs determined for Lot 1: 16.64 - 65,800 pg/mL
Assay-Empfindlichkeit:Siehe Analysezertifikat
Bead-TypTNF alpha [45]
Zur Verwendung mit (Geräte)Luminex™ Geräte
FormatSimplex-Kit
GenTumor necrosis factor
Gen-AliasEGK_14705, TNF-ALPHA
Gen-ID (Entrez)715467
GensymbolTNF
ProduktlinieProcartaPlex
ProteinTumor-Nekrose-Faktor
Protein-SubtypKachektin
ProbentypSerum, Plasma, Zellkulturüberstände, Plasma, Cell Culture Supernatants
ProbenvolumenSerum, Plasma: 25 μl; CCS: 50 μl
VersandbedingungNasseis
UniProt-IDP48094
CombinabilityKombinierbar
ProdukttypSimplex-Kit
Menge96 Tests
Research AreaImmunology, Oncology, Neurobiology, Toxicology, Cytokines
SpeziesNichtmenschlicher Primat
Unit SizeEach
Inhalt und Lagerung
• 1 Fläschchen Erfassungs-Beads (50x)
• 1 Fläschchen biotinylierte Detektionsantikörper (50x)
• 2 Fläschchen NHP-Standard-Mischung A (gefriergetrocknet)

Bei 2 – 8 °C lagern.

Häufig gestellte Fragen (FAQ)

What is the size of the Luminex beads you currently use?

The beads used in our Luminex instrument-compatible ProcartaPlex and QuantiGene Plex assays are 6.5 micron superparamagnetic beads.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

I am interested in performing Luminex assays using BioSource kits, and I have a Luminex xMAP system. Besides the kits and system, what other reagents and equipment will I need?

The following is a list of general lab supplies that are required for running BioSource immunoassays on the Luminex xMAP system:
1) Sonicating water bath
2) Orbital shaker
3) Vortexer
4) Repeating and/or multi-channel pipetter (not required, but recommended)
5) Calibrated adjustable precision pipettes, with disposable plastic tips
6) Glass/plastic tubes and racks for preparing reagents
7) Graduated cylinder and container for preparing wash solution
8) Aluminum foil
9) Deionized or distilled water.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

Do the Luminex beads require special care in handling?

The Luminex beads should be protected from light because they are susceptible to photobleaching. We recommend protecting the beads by keeping containers covered with aluminum foil during all incubation steps, and exercising care during handling. The beads should not be frozen, subjected to excessive heat, or exposed to organic solvents.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

Why would the Luminex acquisition software display "Sample Empty" messages during analysis?

(1) The user did not properly aliquot the diluted beads, such that no beads were actually added to the wells (make sure that the bead concentrates are sonicated and vortexed well, then check the pipet tip to ensure that air bubbles were not drawn up)
(2) The user missed loading diluted beads to some wells, which is likely since the small volume is clear and difficult to visualize in the clear plastic plate (we have now addressed this customer difficulty by coloring each of the Buffer Reagent Kit components)
(3) The user applied too much vacuum pressure at some point during the wash steps, or allowed the pressure to spike even once, such that the filter membrane tore in a few wells releasing the beads (make sure that the vacuum manifold pressure is kept below 5mm/in Hg, depending on their system -- a good rule of thumb is that it should take a full 3-second count to GENTLY empty the wells of 200uL)
(4) The user did not properly sonicate and vortex the beads prior to dilution, such that the percent of bead aggregation was high and the instrument was unable to find enough single beads to meet the events/bead value designated by the customer (make sure that the Bead Concentrate tube is put into the waterbath all the way to the cap, since the tube is hollow until the top third)
(5) The user lost beads by shaking the plate too aggressively or handling it improperly (make sure that the orbital shaker is set to a speed that allows for maximum vortex in the wells without spillage)
(6) The user exposed the beads to an excess of light during storage or running of the assay, such that some but not all of the beads were photobleached and therefore falling outside the acceptable range for each bead region (make sure that the plate is covered on the top/sides with foil throughout the assay, away from Windows and spotlights, and that the bead component of the kits is stored in the dark)*
(7) There was a clog in the sample needle, such that the instrument was unable to take up enough sample to meet the number of events requested per bead region (suggest that the user follow the manual instructions for dislodging a clog, which include several Back Flush steps and may require removal of the needle for sonication with probe alignment).

* Some of the older Antibody Bead Kits still have clear plastic tops instead of black ones. In cases where customers store kits in lit refrigerators, or keep them open on the lab bench, even a few hours of light exposure is enough to photobleach beads. It is important to note, in general, that higher number bead regions are more susceptible to photobleaching. In order to draw conclusions about the source of the difficulty, we would ask to see the data, specifically the Masterplex QT file, which would enable us to examine the pattern of "Sample Empty" occurrences in addition to the bead counts per well.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

What are the Luminex beads made of?

The beads are made of polystyrene.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

Zitierungen und Referenzen (3)

Zitierungen und Referenzen
Abstract
Establishment of disseminated intravascular coagulation (DIC) model by a single iv administration of Escherichia coli-derived lipopolysaccharide (LPS) to cynomolgus monkeys and evaluation of its pathophysiological status.
Authors:Minomo H, Inoue K, Sakaki S, Okazaki T, Kobayashi K, Inoue K, Miyata A
Journal:J Pharmacol Sci
PubMed ID:28215474
'We prepared a DIC model by administrating LPS to cynomolgus monkeys, and investigated its potential for evaluations of new medicines for DIC therapy. Peripheral blood mononuclear cells (PBMC) collected from cynomolgus monkeys were incubated with LPS (8 types), and TNF-a levels in the media were measured. LPS from Escherichia coli ... More
Liver macrophage-associated inflammation correlates with SIV burden and is substantially reduced following cART.
Authors:Fisher BS, Green RR, Brown RR, Wood MP, Hensley-McBain T, Fisher C, Chang J, Miller AD, Bosche WJ, Lifson JD, Mavigner M, Miller CJ, Gale M, Silvestri G, Chahroudi A, Klatt NR, Sodora DL
Journal:PLoS Pathog
PubMed ID:29466439
Liver disease is a leading contributor to morbidity and mortality during HIV infection, despite the use of combination antiretroviral therapy (cART). The precise mechanisms of liver disease during HIV infection are poorly understood partially due to the difficulty in obtaining human liver samples as well as the presence of confounding ... More
STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques.
Authors:Yamamoto T, Kanuma T, Takahama S, Okamura T, Moriishi E, Ishii KJ, Terahara K, Yasutomi Y
Journal:Sci Rep
PubMed ID:30976083
To achieve a functional cure for HIV, treatment regimens that eradicate latently HIV-infected cells must be established. For this, many groups have attempted to reactivate latently-infected cells to induce cytopathic effects and/or elicit cytotoxic T lymphocyte (CTL)/NK cell-mediated immune responses to kill these cells. We believe that not only the ... More